Logo Image
|Articles|March 19, 2008

NovoLog insulin aspart approved for pediatric use

The Food and Drug Administration approved the NovoLog insulin pump in pediatric patients, aged 4 to 18.

Related Content

Latest CME

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?
Video

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Jordan Axelrad, MD, MPH, FACG, FCCF; Jessica R. Allegretti, MD, MPH; Florian Rieder, MD

View more